VKTX Market Cap & Key Metrics
Viking Therapeutics, Inc.
$26.95
+$1.48(+5.81%)
33
Overall
60
Value
10
Tech
31
Quality
Market Cap
$3.20B
Volume
3.21M
52W Range
$25.77 - $43.15
Target Price
$91.28
VKTX market cap is $3.20B. This page lists Viking Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
VKTX Key Metrics
- Market cap
- $3.20B
- EPS estimate, current year
- $-4.46
- EPS growth, 3-year
- -52.47%
- Value score
- 60
- Quality score
- 31
- Technical score
- 10
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| EBITDA | -$392.91M | -$150.56M | -$100.62M | -$90.61M | -$55.39M |
| EPS | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VKTX | $26.95 | +5.8% | 3.21M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viking Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW